NSE filing, NSE: WAAREERTL. Summary written from the filing by ALFA Finder's alert engine.
Waaree Renewable Technologies Ltd: key numbers
- Share price
- ₹672.60
- Market cap
- ₹7,021 Cr
- Revenue (annual)
- ₹3,331 Cr
- Net profit (annual)
- ₹478.7 Cr
- P/E (TTM)
- 15.1×Sector 21.0×
- Promoter holding
- 74.30%-0.02% QoQ
- FII holding
- 2.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Waaree Renewable Technologies Ltd
All →Waaree Renewable Technologies Bags New Order from A leading Independent Power Producer Company
Waaree Renewable Technologies received a 450 MWp solar EPC order from an unnamed IPP. Completion is scheduled for FY 2027-28.
- From
- A leading Independent Power Producer (IPP) Company
- Execution
- FY 2027-28
- solar power project EPC capacity
- 450 MWp
Waaree Renewable Technologies Order Update
Waaree Renewable Technologies revised scope and capacity under two solar EPC Letters of Award. Aggregate capacity under the awards stands at 800 MWac / 1,109 MWp.
- Execution
- Scheduled completion during financial year 2027-28, as per the terms of the order
- solar PV capacity under EPC LoAs
- 800.0 MWac
Waaree Renewable Technologies Earnings Call Transcript: Key Takeaways
Revenue grew 36.5% YoY, but execution slowed significantly this quarter due to developer-led land and connectivity delays.
Waaree Renewable Technologies Investor Presentation: Key Takeaways
Waaree RTL reported H1 FY27 revenue of ₹1,982 Cr, scaling solar EPC and T&D operations. Strategy focuses on integrated energy transition including BESS, floating solar, and transmission via APSPL acquisition.
Waaree Renewable Technologies Results Update
Waaree Renewable Technologies reported Q2 FY27 revenue of Rs. 1,057.84 Crore and PAT of Rs. 81.48 Crore. The unexecuted order book remains strong at Rs. 5,500 Crore.
Waaree Renewable Technologies Q2 FY27 Results: Net Profit ₹81.5 Cr, Down 30.0% YoY
Waaree Renewable Technologies Ltd reported revenue from operations of ₹1,058 Cr (+36.5% YoY) and net profit of ₹81.5 Cr (-30.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹81.5 Cr · -30.0% YoY
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.